Aptahem’s cooperation with Seattle Children’s Hospital increases the understanding of Apta-1
2019-06-11
Aptahem (publ), a biotechnology company that develops aptamer-based pharmaceuticals for the treatment of life-threatening conditions in which a combination of coagulation and inflammation are involved, announces today that the cooperation with the Seattle Children’s Hospital has now generated the...
Read More